HC Wainwright Comments on Transcat, Inc.’s FY2025 Earnings (NASDAQ:TRNS)

Transcat, Inc. (NASDAQ:TRNS) – Stock analysts at HC Wainwright reduced their FY2025 earnings per share estimates for Transcat in a report issued on Wednesday, May 22nd. HC Wainwright analyst S. Buck now expects that the scientific and technical instruments company will post earnings of $1.88 per share for the year, down from their prior estimate of $2.31. HC Wainwright has a “Buy” rating and a $156.00 price objective on the stock. The consensus estimate for Transcat’s current full-year earnings is $1.98 per share.

Several other research analysts have also recently commented on TRNS. Oppenheimer increased their price target on Transcat from $125.00 to $160.00 and gave the company an “outperform” rating in a research report on Wednesday. Northland Securities lowered Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Northland Capmk lowered Transcat from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. Finally, TheStreet upgraded Transcat from a “c+” rating to a “b” rating in a research note on Wednesday, January 31st. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $134.50.

Transcat Stock Up 1.9 %

Shares of TRNS stock traded up $2.60 on Friday, hitting $137.07. 7,667 shares of the stock were exchanged, compared to its average volume of 39,512. The company has a current ratio of 3.37, a quick ratio of 2.81 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $1.21 billion, a P/E ratio of 86.21 and a beta of 0.61. The business has a 50-day moving average of $113.66 and a 200 day moving average of $106.14. Transcat has a fifty-two week low of $81.26 and a fifty-two week high of $147.00.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Virtu Financial LLC purchased a new stake in shares of Transcat in the first quarter worth approximately $224,000. State Board of Administration of Florida Retirement System bought a new position in shares of Transcat in the third quarter valued at approximately $207,000. Arizona State Retirement System bought a new position in Transcat during the third quarter valued at $213,000. Price T Rowe Associates Inc. MD grew its holdings in Transcat by 13.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,347 shares of the scientific and technical instruments company’s stock valued at $262,000 after purchasing an additional 284 shares during the period. Finally, Quantbot Technologies LP grew its holdings in Transcat by 118.2% during the third quarter. Quantbot Technologies LP now owns 2,370 shares of the scientific and technical instruments company’s stock valued at $232,000 after purchasing an additional 1,284 shares during the period. 98.34% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Transcat

In related news, CEO Lee D. Rudow sold 3,343 shares of the firm’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $124.12, for a total transaction of $414,933.16. Following the sale, the chief executive officer now owns 103,692 shares of the company’s stock, valued at approximately $12,870,251.04. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, CEO Lee D. Rudow sold 2,373 shares of the business’s stock in a transaction dated Saturday, March 30th. The stock was sold at an average price of $111.43, for a total value of $264,423.39. Following the transaction, the chief executive officer now directly owns 103,688 shares of the company’s stock, valued at approximately $11,553,953.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Lee D. Rudow sold 3,343 shares of the business’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $124.12, for a total value of $414,933.16. Following the completion of the transaction, the chief executive officer now directly owns 103,692 shares in the company, valued at $12,870,251.04. The disclosure for this sale can be found here. 4.20% of the stock is currently owned by company insiders.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.